In September 2020, a new, more contagious strain of the virus that causes COVID-19 was detected in Europe. However, early research indicates that those who have received two doses of the Pfizer-BioNTech vaccine are producing sufficient antibodies to combat even the new strain. Talk about exceeding expectations!